Ocugen Secures Full $130M Convertible Note Offering, Extends Cash Runway to 2028

summarizeSummary

Ocugen finalized its $130 million convertible note offering, including a $15 million over-allotment, securing $112.6 million in net proceeds to repay debt and extend its cash runway into 2028.

check_boxKey Events

• Full Offering Completed

  Ocugen closed its private offering of 6.75% Convertible Senior Notes due 2034, totaling $130.0 million in aggregate principal amount.

• Over-Allotment Option Exercised

  The initial purchaser fully exercised its option to purchase an additional $15.0 million in notes, completing the offering that was initially announced with this option.

• Significant Net Proceeds

  The offering is expected to result in approximately $112.6 million in net proceeds for Ocugen.

• Debt Repayment & Cash Runway Extended

  Approximately $32.7 million of the net proceeds were used to fully repay an outstanding loan, and the remaining funds are expected to extend the company's cash runway into 2028.

auto_awesomeAnalysis

This filing confirms the full exercise of the over-allotment option for Ocugen's convertible senior notes, bringing the total offering to $130 million. The net proceeds of $112.6 million significantly bolster the company's liquidity, allowing it to repay $32.7 million in debt and extend its cash runway into 2028. This is a critical development for a company that recently disclosed a "going concern" warning, providing essential funding to advance its late-stage gene therapy pipeline.